33 completed, 20 unknown, 5 not yet recruiting, 5 terminated. 24 Not applicable, 21 Phase 2, 7 Phase 1, 5 Phase 3, 2 Phase 4.
Follow Central Serous Chorioretinopathy: new trials by email Literature Review of Central Serous Chorioretinopathy trials Research Report on Central Serous Chorioretinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial Faricimab, Sham - Central Serous Chorioretinopathy (CSC) | Phase 2 | Not yet recruiting | Singapore National Eye Centre | 50 | 2026-12-01 | 2026-07-02 |
| Mindfulness for Central Serous Chorioretinopathy Mindfulness - Central Serous Chorioretinopathy | Not applicable | Not yet recruiting | King's College Hospital NHS Trust | 100 | 2026-10-01 | 2026-08-28 |
| the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy Live Combined Bifidobacterium, Placebo - Central Serous Chorioretinopathy | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 400 | 2026-05-27 | 2026-05-27 |
| Wide Field OCTA in Ocular Diseases Age - Related Macular Degeneration (AMD), Diabetic Macular Edema | Not yet recruiting | IRCCS San Raffaele | 200 | 2026-01-01 | 2025-12-30 | |
| Prospective Geometric Analysis of Ultra-Widefield OCTA Characteristics in Central Serous Chorioretinopathy Patients Central Serous Chorioretinopathy (CSC) | Not yet recruiting | Sun Yat-sen University | 120 | 2025-12-18 | 2026-01-16 | |
| Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy melatonin 3mg, Placebo Drug - Central Serous Chorioretinopathy, Melatonin | Phase 2 / Phase 3 | Not yet recruiting | Mohsen Pourazizi | 48 | 2025-02-01 | 2025-02-05 |
| Treatment of Recurrent and Multifocal Central Serous Chorioretinopathy 577 nm Subthreshold Micropulse Laser - Central Serous Retinopathy (CSR), Sub-Threshold Laser | Not applicable | Completed | Benha University | 40 | 2024-07-01 | 2026-10-22 |
| Combination of Micropulse Laser With or Without Photodynamic Therapy for Chronic Central Serous Chorioretinopathy Central Serous Chorioretinopathy, Micropulse Laser | Unknown | Beijing Hospital | 60 | 2024-06-15 | 2024-06-21 | |
| Central Serous Chorioretinopathy and Micropulse Laser Treatment Subthreshold Micropulse Laser Treatment - Central Serous Chorioretinopathy | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 36 | 2023-05-31 | 2025-09-23 | |
| Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE micropulse laser - Central Serous Chorioretinopathy | Not applicable | Withdrawn | University Hospital, Bordeaux | 2023-05-11 | 2023-05-30 | |
| Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations OCT Imaging Using Device N, OCT Imaging Using Device C - Age-Related Macular Degeneration, Diabetic Retinopathy | Not applicable | Terminated | NYU Langone Health | 42 | 2023-03-30 | 2024-11-05 |
| Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy - Central Serous Chorioretinopathy | Completed | Dar El Oyoun Hospital | 16 | 2023-02-28 | 2023-05-06 | |
| Two Patterns of Micropulse Laser in the Treatment of Chronic Central Serous Chorioretinopathy 100μm laser spot diameter micropulse laser, 200μm laser spot diameter micropulse laser - Central Serous Chorioretinopathy | Not applicable | Unknown | Beijing Hospital | 50 | 2023-02-01 | 2023-01-18 |
| Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy 2RT subthreshold nanosecond laser - active, 2RT subthreshold nanosecond laser - sham - Central Serous Chorioretinopathy | Not applicable | Unknown | Nova Eye Medical Pty Ltd. | 60 | 2022-10-18 | 2024-06-24 |
| Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy Verteporfin - Central Serous Chorioretinopathy | Unknown | Helse Stavanger HF | 50 | 2022-10-01 | 2024-03-18 | |
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome | Phase 2 / Phase 3 | Unknown | Benha University | 50 | 2022-04-14 | 2022-04-20 |
| Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study Central Serous Chorioretinopathy | Unknown | Chinese University of Hong Kong | 350 | 2022-03-11 | 2023-08-30 | |
| Crocin Supplementation in CSCR Crocin, Placebo - Chorioretinopathy, Central Serous | Phase 1 | Unknown | Shiraz University of Medical Sciences | 40 | 2021-07-01 | 2021-10-28 |
| Pilot Study on Deep Learning in the Eye Image classification using deep learning algorithm - Central Serous Chorioretinopathy, Diabetic Retinopathy | Unknown | CRG UZ Brussel | 120 | 2021-02-01 | 2021-01-07 | |
| Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph Software assisted imaging diagnosis - Diabetic Retinopathy, Retinal Vein Occlusion | Completed | Visionary Intelligence Ltd. | 748 | 2020-08-10 | 2021-12-30 |
Showing 20 of 70. Sign in to see all of them.
Macular Degeneration (11) · Diabetic Retinopathy (7) · Retinal Diseases (7) · Macular Edema (4) · Retinal Vein Occlusion (4) · Choroidal Neovascularization (3) · Geographic Atrophy (3) · Retinitis Pigmentosa (3) · Epiretinal Membrane (2) · Myopia (2) · Ocular Hypertension (2) · Polypoidal Choroidal Vasculopathy (2) · Retinal Artery Occlusion (2) · Retinal Perforations (2)
Eye Diseases (69) · Retinal Diseases (63) · Retinal Degeneration (13) · Endocrine System Diseases (9) · Cardiovascular Diseases (8) · Vascular Diseases (8) · Diabetes Complications (7) · Diabetes Mellitus (7) · Diabetic Angiopathies (7) · Pathological Conditions, Signs and Symptoms (7) · Uveal Diseases (7) · Choroid Diseases (6) · Metaplasia (6) · Neovascularization, Pathologic (6) · Pathologic Processes (6)
Eplerenone (6) · Bevacizumab (3) · Finasteride (3) · Blood Specimen Collection (2) · Photochemotherapy (2) · Verteporfin (2) · aflibercept (2) · salicylhydroxamic acid (2) · 1-phenyl-3,3-dimethyltriazene (1) · Amoxicillin (1) · Antioxidants (1) · Dexamethasone (1) · Dosage Forms (1) · Drugs, Generic (1) · Intravitreal Injections (1)
National Eye Institute (NEI) (5) · Peking University People's Hospital (3) · Beijing Hospital (2) · Benha University (2) · Samsung Medical Center (2) · Tel-Aviv Sourasky Medical Center (2) · Wills Eye (2) · Ankara Universitesi Teknokent (1) · Asan Medical Center (1) · Asociación para Evitar la Ceguera en México (1) · CRG UZ Brussel (1) · Centre Hospitalier Universitaire de Besancon (1) · Chinese University of Hong Kong (1) · Columbia University (1) · CynosureLutronic (1)
United States (17) · China (8) · South Korea (5) · Egypt (3) · Germany (3) · Israel (3) · Austria (2) · France (2) · Iran (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · Hong Kong (1) · Italy (1)
Emily Y Chew, M.D. (2) · Mingwei Zhao, M.D (2) · Ahmed A Abdelshafy, MD (1) · Alireza Javadzadeh (1) · Allen Ho, MD (1) · Andre J Witkin, MD (1) · Andreas Ebneter (1) · Carsten Framme, MD (1) · Catherine B Meyerle, MD (1) · Catherine Meyerle, M.D. (1) · Chaim Gadi Wollstein, MD (1) · Cheng-Kuo Cheng, MD (1) · Chenjin Jin (1) · Chenjin Jin, PH.D (1) · Danny Siu-Chun Ng, FHKAM(Ophth) (1)
PMID 40522203, PMID 16758179, PMID 16937094, PMID 18394706, PMID 20554506, PMID 20930852, PMID 21273946, PMID 21427570, PMID 22079961, PMID 23410821, PMID 25555191, PMID 25595177, PMID 27841848, PMID 29545953, PMID 29546474, PMID 30505108, PMID 31516734, PMID 31601186, PMID 32343102, PMID 32727733, PMID 33107400, PMID 38212607, PMID 39557692